Multisystemic Impact of RNF213 Arg4810Lys: A Comprehensive Review of Moyamoya Disease and Associated Vasculopathies
International Journal of Molecular Sciences · 14.08.2025 · 26 (16) · 7864
DOI: 10.3390/ijms26167864 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.08.2025. Verfasst von Eva Bagyinszky und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial and Environmental Engineering, Graduate School of Environment, Gachon University, Seongnam 13120, Republic of Korea. Hauptthemen laut MEDLINE: Moyamoya Disease, Ubiquitin-Protein Ligases, Adenosine Triphosphatases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation Korea, National Research Foundation of Korea.
Abstract (Originalsprache)
The ring finger protein 213 (RNF213) Arg4810Lys variant has been previously identified as a significant risk factor for Moyamoya disease (MMD), particularly in East Asian populations. This review explores the broader impact of the Arg4810Lys mutation on various cerebrovascular conditions, including Moyamoya syndrome (MMS), intracranial artery stenosis, quasi-Moyamoya syndromes, ischemic stroke, and intracranial atherosclerosis. Beyond the brain, it is also implicated in pulmonary arterial hypertension, coronary artery disease, and renal artery stenosis, emphasizing its systemic effects. Functional studies suggest that RNF213 Arg4810Lys alters angiogenic signaling, endothelial cell function, vascular remodeling, and immune response pathways, especially when influenced by environmental stressors, like hypoxia or inflammation. The gene dosage of Arg4810Lys significantly affects disease phenotypes, with homozygous carriers typically experiencing earlier onset with increased severe symptoms. The variant also exhibits incomplete penetrance and frequently co-occurs with additional genetic alterations, including trisomy, KIF1A, FLNA, and PCSK9 mutations, which complicates its pathogenicity. A comprehensive understanding of RNF213 Arg4810Lys’s systemic impact is essential to developing effective risk assessment strategies, personalized treatments, and targeted therapies for associated vascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Industrial and Environmental Engineering, Graduate School of Environment, Gachon University, Seongnam 13120, Republic of Korea.
- Department of Neurology, Soonchunhyang University Hospital, Cheonan 31151, Republic of Korea.
- Department of Bionano Technology, Gachon Medical Research Institute, Gachon University, Mirae 1 Building, 1342 Seongnamdaero, Sujeong-gu, Seongnam 13210, Republic of Korea.
ORCID-Profile: Eva Bagyinszky, YoungSoon Yang, Seong Soo A An
Förderung
- National Research Foundation Korea
- National Research Foundation of Korea
Zitieren
APA
Bagyinszky, E., Yang, Y., & An, S. S. A. (2025). Multisystemic Impact of RNF213 Arg4810Lys: A Comprehensive Review of Moyamoya Disease and Associated Vasculopathies. International Journal of Molecular Sciences, 26(16), 7864. https://doi.org/10.3390/ijms26167864
Vancouver
Bagyinszky E, Yang Y, An SSA. Multisystemic Impact of RNF213 Arg4810Lys: A Comprehensive Review of Moyamoya Disease and Associated Vasculopathies. International Journal of Molecular Sciences. 2025;26(16):7864. doi:10.3390/ijms26167864
BibTeX
@article{Bagyinszky2025,
author = {Bagyinszky, Eva and Yang, YoungSoon and An, Seong Soo A},
title = {Multisystemic Impact of RNF213 Arg4810Lys: A Comprehensive Review of Moyamoya Disease and Associated Vasculopathies},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {16},
pages = {7864},
doi = {10.3390/ijms26167864}
}
EUVIMED